

LATEST
-
REGULATORY
Pharma Calls for Drug Price Hikes, Govt Purchases to Spur MCM Investment
November 16, 2026 -
REGULATORY
Stable Supply Drives Japan’s Generic Drug Delistings: Jiho Tally
November 16, 2026 -
BUSINESS
Fuji Poised to Hit 10 Billion Yen Biosimilar Sales Mark, Led by Eylea Follow-On
November 16, 2026
On paper, things should be looking up for Japan’s pharmaceutical wholesalers. Industry expectations are mounting that the average gap between NHI and market prices will narrow further in FY2026 from the previous year’s record low of 4.8%.A shrinking gap should…
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…


